Sanoculis is an Israel-based company which develops and markets three novel surgical techniques for the treatment of Glaucoma: MIMS® (Minimally Invasive Micro Sclerostomy), inferonasal MIMS® (after failed Trab) and MINT™ (Minimally Invasive Nasal Trabeculostomy). These techniques are simple, fast, and minimally invasive. They require no stitches, eye-patch, implant or stent and thus leave nothing behind. […]
Company Founded in 2019 Occyo leverages direct clinical insights from its ophthalmologist founders, Vito Romano, MD, and Bernhard Steger, MD. The need for standardized ocular surface imaging originated from their clinical experience. The company has grown to 18 employees, focusing on innovative medical solutions for ophthalmology and telemedicine. Market Despite advancements, current ocular surface imaging […]
DiagnosTear is a leading ophthalmic company developing and commercializing disruptive diagnostic solutions for better management of eye diseases. DiagnosTear’s TeaRx™ technology is a diagnostic platform intended for Point-of-Care Testing (POCT) of ophthalmic pathologies through multi-parameter composition analysis of the tear fluid. TeaRx™ technology is based on a minute sample of tear fluid taken with a unique, single-use, microfluidic […]
Over the past several decades, cataract extraction and/or refractive lens exchange (RLE) have been two of the most common surgeries worldwide with significant visual outcomes. Despite the explosion of innovations designed to optimise the visual outcome of the procedure, several postoperative complications may occur related to the fibrotic reaction and collapse of the human lens […]
ECS01 – The Eyelib Company website: www.eye-yon.com The Eyelib – A multi-ocular robotic platform to automate eye measurements and comprehensive AI-powered diagnosis Assouline1,* 1Iena vision, Paris, France Mikajaki is an emerging startup from Geneva, which designs and manufactures the Eyelib, a multi-ocular robotic platform to automate measurements of eyes, armed with in-house cutting edge AI […]
At CustomLens AI, our mission is to achieve universal spectacle freedom post-cataract surgery. Despite advancements, over 20 million patients still require glasses post-surgery, with premium intraocular lens (IOL) utilization at only 15%. Our goal is to increase this adoption to over 50% within the next five years, advancing the pursuit of widespread spectacle independence. Surgeons […]
Keranova is an innovative clinical stage company developing an intelligent surgical system for ophthalmic surgery in cataract and refractive applications. Recent clinical data will be presented and new workflow and outcomes driven capabilities will be shared for the first time. The surgical platform is based on proprietary technology covered in multiple patents and refined into […]
NovoMolDX introduces a breakthrough solution – the Biomarker Pathfinder Test supported by cutting-edge AI technology. The test was developed by a seasoned team of scientists at GROW Research Laboratory, a part of Narayana Nethralaya. It provides accurate results in less than 2 hours, while the built-in AI software generates the recommended line of treatment. The […]
Facial paralysis impacts over 4,000,000 people worldwide each year, due to Bell’s palsy, brain surgery, stroke, Parkinson’s and other diseases. Eye closure is generally regarded as the top functional priority restoration in patients experiencing facial paralysis. The absence of blinking can lead to extremely painful corneal ulceration and severe dry eye, either can cause visual […]
At Mikajaki, we are pioneering the development of a multi-ocular AI-driven robotic platform designed for automated examination and diagnosis in ophthalmology. Our innovative suite of products offers a comprehensive solution for end-to-end ophthalmological diagnosis. It begins with our Ariane suite, a virtual agent that collects subjective patient information to enhance diagnostic accuracy and predict ocular […]
